SlideShare a Scribd company logo
Solid State Services
Supporting the development of APIs
from invention to launch




 > Polymorph Studies
 > Physical Form Screening & Selection
 > Crystallisation Development
 > Troubleshooting
 > Physical Form Characterisation
 > Analytical Method Development
   & Validation
 > Counterfeit Analysis
 > Scientific Litigation &
   Prosecution Support
 > Inhalation Services
 > Preformulation Support




API Services &
Chemical Development
www.almacgroup.com
Commercial Services




                                      Solid State Services                                                                                         Scientific Litigation and
                                                                                                                                                   Prosecution Support
                                      Supporting the development of APIs from invention to launch

                                      Almac’s Physical Sciences Group has extensive experience of API development, our comprehensive range
                                                                                                                                                   Providing expertise in Pharmaceutical IP from expert witnessing to prosecution support
Clinical Technologies




                                      of solid state services and know-how will help strengthen the success of your product. Our solid form
                                      investigations are driven by science not robotics, with highly trained chemists and analysts directing the   Almac has served the global pharmaceutical industry for over 30 years in discovery, process development,
                                      studies. These scientists have the ability to solve virtually any problem presented to them. They know       manufacturing, formulation and clinical services, offering the most comprehensive range of integrated drug
                                      that finding and consistently producing the drug in its optimal physical form is vital to the success of     development services. We can utilise over 300 highly skilled scientists who are organic chemists, solid state
                                      your drug development programme.                                                                             chemists, analysts, and formulation scientists, operating in state of the art facilities. Our expertise, built from a
Clinical Trial Supply




                                                                                                                                                   large volume of diverse projects, puts us in a unique position to provide expert witnessing services to pharma
                                                                                                                                                   litigation cases as a testifying or non-testifying witness. We provide services to both infringement and
                                                                                                                                                   Paragraph IV cases.


                                              Polymorph                                     Characterisation                                       We provide technical expertise to assist in successful patent prosecution. This service includes technical
                                              >   Screening                                 >   Drug substance                                     consultancy for IP and technical support for successful prosecution to overcome rejections and oppositions.
Analytical Services




                                              >   Selection                                 >   Drug product
                                              >   Stable form determination
                                                                                            Routine Analyses
                                              Physical Form Screen &                        >   Lot release
                                              Selection                                     >   GMP compliant
                                                                                                                                                             Expert Witness Services                                IP Support Services
                                              >   Salt, cocrystal &
Pharmaceutical Development




                                                  amorphous screens                         Analytical Method Development                                    Infringement support                                   Intellectual Property Support
                                              >   Selection of optimum form                 & Validation                                                     >   Laboratory testing of API & drug product           >   Technical consultancy
                                                  for development                           >   Lot release & regulatory                                     >   API solid form analysis in the drug product        >   Laboratory testing to strengthen the patent
                                              >   Reproducible solid form                       compliance                                                   >   Reverse engineering of drug products
                                                  of the API                                                                                                 >   Strategy development                               Patent Application & Prosecution
                                                                                            Counterfeit Analysis                                             >   Expert report                                      >   Prior art reproduction
                                              Troubleshooting:                              >   Impurity profile                                             >   Expert witnessing                                  >   Reproduction of specifications & examples
                                              API Issues                                    >   API solid form analysis in the
                                              >   Crystallinity, solubility, stability,         drug product                                                 Paragraph IV litigation support                        Patent Opposition Support
                                                                                            >   Reverse engineering of                                       >   ANDA reproduction of API & drug product            >   Laboratory testing
API Services & Chemical Development




                                                  purification & yield
                                                                                                drug products                                                >   Laboratory testing of API & drug product           >   EPO hearing
                                              >   Batch to batch variation
                                              >   Scale up problems                                                                                          >   Strategy development
                                                                                            Inhalation Services                                              >   Expert report
                                              Drug Product Issues                           >   Particle engineering                                         >   Expert witnessing
                                              >   Dissolution                               >   Cocrystals
                                              >   Stability                                 >   Micronisation
                                                                                            >   Amorphous content & control
                                              Crystal Engineering                           >   Moisture content &
                                              >   Crystal modification                          hygroscopicity

                                              Crystallisation Development
                                              >   Process development, scale-up
Biomarker Discovery & Development
www.almacgroup.com
Commercial Services




                                      Preformulation Services
                                      Design and development capability for small molecules and biologics
Clinical Technologies




                                      Our preformulation studies are designed to identify and select the optimal physical form of your
                                      API. We know that by possessing a thorough understanding of the properties of your drug
                                      substance, we can reduce the number of problems in development, lower development costs
                                      and decrease development time.
Clinical Trial Supply




                                              Determining & assessing the                        Peptide structural characterisation
                                              solid state properties                             >   LC-MS
                                              >    Crystallinity                                 >   Absorption & fluorescence
                                              >    Hygroscopicity                                    spectroscopy
                                              >    Particle size, shape &                        >   Circular dichroism spectroscopy
                                                   surface area                                  >   NMR
Analytical Services




                                              >    Moisture/solvent content
                                                                                                 Peptide chemical stability
                                              Solid state stability                              >   Solution state chemical stability to
                                              Solution state stability                               acid, base, oxidising media, light &
                                              Plasma stability                                       elevated temperatures
                                                                                                 >   Solid state chemical stability to
                                              Biopharmaceutical profiling                            light, humidity & temperature
Pharmaceutical Development




                                              >    pH-solubility profile & pKa
                                                   determination
                                                                                                 Formulation development studies
                                              >    Permeability & BCS classification
                                                                                                 >   Effect of pH
                                              >    Solubility in pharmaceutical
                                                                                                 >   Buffer concentration & buffer type
                                                   solvents
                                                                                                 >   Surfactants
                                              >    Solubility in physiological buffers
                                                                                                 >   Complexing agents
                                                                                                 >   Polymers & cosolvents
                                              Animal formulation
                                              development                                        Compatibility & stability studies
                                              >    pH modifications                              >   In a range of containers & closures;
API Services & Chemical Development




                                              >    Cosolvents                                        assessed for peptide adsorption,
                                              >    Surfactants                                       compatibility, glass leachates &
                                              >    Cyclodextrin inclusion complexes                  particulate formation.
                                              >    Lipid based formulations
                                                                                                 Other parameters assessed:
                                              Clinical formulation                               >   Osmolarity
                                              >    Micronised powders/suspensions                >   Viscosity
                                              >    Solid/waxy dispersions                        >   pH
                                              >    Lipid based formulations                      >   Appearance
                                              >    Drug in capsule/bottle                        >   Needle flowability
                                                                                                 >   Identification of impurities
                                                                                                     during stress studies
Biomarker Discovery & Development




                                      For European Enquiries:           For American Enquiries:
                                      Almac                             Almac Group Incorporated
                                      Sciences                          25 Fretz Road
                                      Almac House                       Souderton, PA 18964
                                      20 Seagoe Industrial Estate,      United States of America
                                      Craigavon, BT63 5QD,              T +1 (215) 660 8500
                                      United Kingdom.                   E: sciences@almacgroup.com
                                      T: +44 (0) 28 3833 2200
                                      E: sciences@almacgroup.com
                                      www.almacgroup.com

More Related Content

What's hot

SCYNEXIS Overview 2010
SCYNEXIS Overview 2010SCYNEXIS Overview 2010
SCYNEXIS Overview 2010
brycechaney
 
Pakistan Clinical Research Capacity
Pakistan Clinical Research CapacityPakistan Clinical Research Capacity
Pakistan Clinical Research Capacity
fhroohi
 
2015 RoHS for Gorilla 2319_CE_2015_C1966
2015 RoHS for Gorilla 2319_CE_2015_C19662015 RoHS for Gorilla 2319_CE_2015_C1966
2015 RoHS for Gorilla 2319_CE_2015_C1966Tang Wei
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
Quali Meddweb
Quali MeddwebQuali Meddweb
Quali Meddweb
QualiMedd
 
006 certificate - astm d3161 tas107 - viro reed with netting
006 certificate - astm d3161 tas107 - viro reed with netting006 certificate - astm d3161 tas107 - viro reed with netting
006 certificate - astm d3161 tas107 - viro reed with nettingMaury Janwarin
 
IN-SPEC Catalog 2011
IN-SPEC Catalog 2011IN-SPEC Catalog 2011
IN-SPEC Catalog 2011
rstapf
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...finance40
 
Formulation Solution @ Aizant
Formulation Solution @ AizantFormulation Solution @ Aizant
Formulation Solution @ AizantJaydeep Adhikari
 
Efrac drug brochure
Efrac drug brochureEfrac drug brochure
Anecto iso 11607 2011
Anecto iso 11607 2011Anecto iso 11607 2011
Anecto iso 11607 2011
2expand
 
Clinical Research & Development Factsheet
Clinical Research & Development FactsheetClinical Research & Development Factsheet
Clinical Research & Development FactsheetBilcare Research
 
Scynexis Fully Integrated Drug Discovery & Development 2011 Overview
Scynexis Fully Integrated Drug Discovery & Development 2011 OverviewScynexis Fully Integrated Drug Discovery & Development 2011 Overview
Scynexis Fully Integrated Drug Discovery & Development 2011 Overview
brycechaney
 

What's hot (14)

SCYNEXIS Overview 2010
SCYNEXIS Overview 2010SCYNEXIS Overview 2010
SCYNEXIS Overview 2010
 
TCR Arabia
TCR ArabiaTCR Arabia
TCR Arabia
 
Pakistan Clinical Research Capacity
Pakistan Clinical Research CapacityPakistan Clinical Research Capacity
Pakistan Clinical Research Capacity
 
2015 RoHS for Gorilla 2319_CE_2015_C1966
2015 RoHS for Gorilla 2319_CE_2015_C19662015 RoHS for Gorilla 2319_CE_2015_C1966
2015 RoHS for Gorilla 2319_CE_2015_C1966
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
Quali Meddweb
Quali MeddwebQuali Meddweb
Quali Meddweb
 
006 certificate - astm d3161 tas107 - viro reed with netting
006 certificate - astm d3161 tas107 - viro reed with netting006 certificate - astm d3161 tas107 - viro reed with netting
006 certificate - astm d3161 tas107 - viro reed with netting
 
IN-SPEC Catalog 2011
IN-SPEC Catalog 2011IN-SPEC Catalog 2011
IN-SPEC Catalog 2011
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
 
Formulation Solution @ Aizant
Formulation Solution @ AizantFormulation Solution @ Aizant
Formulation Solution @ Aizant
 
Efrac drug brochure
Efrac drug brochureEfrac drug brochure
Efrac drug brochure
 
Anecto iso 11607 2011
Anecto iso 11607 2011Anecto iso 11607 2011
Anecto iso 11607 2011
 
Clinical Research & Development Factsheet
Clinical Research & Development FactsheetClinical Research & Development Factsheet
Clinical Research & Development Factsheet
 
Scynexis Fully Integrated Drug Discovery & Development 2011 Overview
Scynexis Fully Integrated Drug Discovery & Development 2011 OverviewScynexis Fully Integrated Drug Discovery & Development 2011 Overview
Scynexis Fully Integrated Drug Discovery & Development 2011 Overview
 

Viewers also liked

Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011
Linda_Mccausland
 
Rapidd™
Rapidd™Rapidd™
Rapidd™ejmckee
 
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APIAlmac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
Susan1Beattie
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Susan1Beattie
 
Almac solid state presentation 2013
Almac solid state presentation 2013Almac solid state presentation 2013
Almac solid state presentation 2013Susan1Beattie
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharan
Dipak Shetty
 
Crystals And IP April 2011
Crystals And IP April 2011Crystals And IP April 2011
Crystals And IP April 2011
Linda_Mccausland
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
KBI Biopharma
 
High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...
KBI Biopharma
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysisPatel Parth
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
Mark_Sullivan
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid forms
Linda_Mccausland
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitation
reychemist
 
New drug delivery system by dr.roohna
New drug delivery system by dr.roohnaNew drug delivery system by dr.roohna
New drug delivery system by dr.roohna
Dr Roohana Hasan
 
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Susan1Beattie
 
Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid Form
Simon Curtis
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
Sagar Savale
 

Viewers also liked (17)

Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011Cryst Dev Case Study Dec 2011
Cryst Dev Case Study Dec 2011
 
Rapidd™
Rapidd™Rapidd™
Rapidd™
 
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal APIAlmac: Development and Scale-up of a Photochemical Route to a Steroidal API
Almac: Development and Scale-up of a Photochemical Route to a Steroidal API
 
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012Almac Protein Ligation Technology Webinar Presentation 12 09-2012
Almac Protein Ligation Technology Webinar Presentation 12 09-2012
 
Almac solid state presentation 2013
Almac solid state presentation 2013Almac solid state presentation 2013
Almac solid state presentation 2013
 
Dr.V.chandrasekharan
Dr.V.chandrasekharanDr.V.chandrasekharan
Dr.V.chandrasekharan
 
Crystals And IP April 2011
Crystals And IP April 2011Crystals And IP April 2011
Crystals And IP April 2011
 
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
A Vaccine Approach against HIV-1, Manufacturing Env proteins: from Bench to B...
 
High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...High Throughput PEGylation Process Development – Screening & Optimization Stu...
High Throughput PEGylation Process Development – Screening & Optimization Stu...
 
4016 solid state analysis
4016 solid state analysis4016 solid state analysis
4016 solid state analysis
 
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
NYSAS Solid State Spectroscopy Of Materials (Polymorphism)
 
X-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid formsX-ray Powder Diffraction:exposing the bare bones of solid forms
X-ray Powder Diffraction:exposing the bare bones of solid forms
 
Polymorph Quantitation
Polymorph QuantitationPolymorph Quantitation
Polymorph Quantitation
 
New drug delivery system by dr.roohna
New drug delivery system by dr.roohnaNew drug delivery system by dr.roohna
New drug delivery system by dr.roohna
 
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
Almac - The Manufacture of Peptides for Clinical Trials - 2nd Irish Peptide S...
 
Pharmaceutical Solid Form
Pharmaceutical Solid FormPharmaceutical Solid Form
Pharmaceutical Solid Form
 
Polymorphism
PolymorphismPolymorphism
Polymorphism
 

Similar to Solid State Capabilities

Analytical Capabilities
Analytical CapabilitiesAnalytical Capabilities
Analytical Capabilitiesejmckee
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
Compliance Insight, Inc.
 
Peptide & Protein Capabilities
Peptide & Protein CapabilitiesPeptide & Protein Capabilities
Peptide & Protein Capabilitiesejmckee
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIfinance40
 
Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aandrewjroche
 
Stability
StabilityStability
Stability
Sujin Prabhu
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...finance40
 
Testing Services
Testing ServicesTesting Services
Testing Services
Daniel Schroen, PhD
 
Sweet sensors lecture 7 partners
Sweet sensors lecture 7 partnersSweet sensors lecture 7 partners
Sweet sensors lecture 7 partnersStanford University
 
Axsource overview Nov 2012
Axsource overview Nov 2012Axsource overview Nov 2012
Axsource overview Nov 2012Navneet Sekhon
 
Approval process for Medical related products in Japan, Sceti Medical Lab
Approval process for  Medical related products in Japan, Sceti Medical LabApproval process for  Medical related products in Japan, Sceti Medical Lab
Approval process for Medical related products in Japan, Sceti Medical Lab
echangeurba
 
Sterling Medical Device Company Profile 2015
Sterling Medical Device Company Profile 2015Sterling Medical Device Company Profile 2015
Sterling Medical Device Company Profile 2015Daniela Levy
 
Podd slide deck mark kontny
Podd slide deck   mark kontnyPodd slide deck   mark kontny
Podd slide deck mark kontnyConferenceForum
 
Progamma Us
Progamma UsProgamma Us
Progamma Us
Ady Sadek E.
 
Protein Formulation Development
Protein Formulation DevelopmentProtein Formulation Development
Protein Formulation Development
Integrity Bio
 

Similar to Solid State Capabilities (20)

Analytical Capabilities
Analytical CapabilitiesAnalytical Capabilities
Analytical Capabilities
 
Ils Information
Ils InformationIls Information
Ils Information
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Peptide & Protein Capabilities
Peptide & Protein CapabilitiesPeptide & Protein Capabilities
Peptide & Protein Capabilities
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_IIIthermo fisher  ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
thermo fisher ED886123-7163-46F5-8387-5F57485F786B_FINAL09SHOW_III
 
Lsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09aLsl Bio Pharm Linkedin 04 09a
Lsl Bio Pharm Linkedin 04 09a
 
Stability
StabilityStability
Stability
 
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...thermo fisher  BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
thermo fisher BE83EA55-53AE-4224-AA31-E1B6E6FB41A4_UBSWestCoastLifeScienceBu...
 
Testing Services
Testing ServicesTesting Services
Testing Services
 
Sweet sensors lecture 7 partners
Sweet sensors lecture 7 partnersSweet sensors lecture 7 partners
Sweet sensors lecture 7 partners
 
Axsource overview Nov 2012
Axsource overview Nov 2012Axsource overview Nov 2012
Axsource overview Nov 2012
 
Approval process for Medical related products in Japan, Sceti Medical Lab
Approval process for  Medical related products in Japan, Sceti Medical LabApproval process for  Medical related products in Japan, Sceti Medical Lab
Approval process for Medical related products in Japan, Sceti Medical Lab
 
Scientific
ScientificScientific
Scientific
 
Sterling Medical Device Company Profile 2015
Sterling Medical Device Company Profile 2015Sterling Medical Device Company Profile 2015
Sterling Medical Device Company Profile 2015
 
Podd slide deck mark kontny
Podd slide deck   mark kontnyPodd slide deck   mark kontny
Podd slide deck mark kontny
 
Progamma Us
Progamma UsProgamma Us
Progamma Us
 
Protein Formulation Development
Protein Formulation DevelopmentProtein Formulation Development
Protein Formulation Development
 

Solid State Capabilities

  • 1. Solid State Services Supporting the development of APIs from invention to launch > Polymorph Studies > Physical Form Screening & Selection > Crystallisation Development > Troubleshooting > Physical Form Characterisation > Analytical Method Development & Validation > Counterfeit Analysis > Scientific Litigation & Prosecution Support > Inhalation Services > Preformulation Support API Services & Chemical Development www.almacgroup.com
  • 2. Commercial Services Solid State Services Scientific Litigation and Prosecution Support Supporting the development of APIs from invention to launch Almac’s Physical Sciences Group has extensive experience of API development, our comprehensive range Providing expertise in Pharmaceutical IP from expert witnessing to prosecution support Clinical Technologies of solid state services and know-how will help strengthen the success of your product. Our solid form investigations are driven by science not robotics, with highly trained chemists and analysts directing the Almac has served the global pharmaceutical industry for over 30 years in discovery, process development, studies. These scientists have the ability to solve virtually any problem presented to them. They know manufacturing, formulation and clinical services, offering the most comprehensive range of integrated drug that finding and consistently producing the drug in its optimal physical form is vital to the success of development services. We can utilise over 300 highly skilled scientists who are organic chemists, solid state your drug development programme. chemists, analysts, and formulation scientists, operating in state of the art facilities. Our expertise, built from a Clinical Trial Supply large volume of diverse projects, puts us in a unique position to provide expert witnessing services to pharma litigation cases as a testifying or non-testifying witness. We provide services to both infringement and Paragraph IV cases. Polymorph Characterisation We provide technical expertise to assist in successful patent prosecution. This service includes technical > Screening > Drug substance consultancy for IP and technical support for successful prosecution to overcome rejections and oppositions. Analytical Services > Selection > Drug product > Stable form determination Routine Analyses Physical Form Screen & > Lot release Selection > GMP compliant Expert Witness Services IP Support Services > Salt, cocrystal & Pharmaceutical Development amorphous screens Analytical Method Development Infringement support Intellectual Property Support > Selection of optimum form & Validation > Laboratory testing of API & drug product > Technical consultancy for development > Lot release & regulatory > API solid form analysis in the drug product > Laboratory testing to strengthen the patent > Reproducible solid form compliance > Reverse engineering of drug products of the API > Strategy development Patent Application & Prosecution Counterfeit Analysis > Expert report > Prior art reproduction Troubleshooting: > Impurity profile > Expert witnessing > Reproduction of specifications & examples API Issues > API solid form analysis in the > Crystallinity, solubility, stability, drug product Paragraph IV litigation support Patent Opposition Support > Reverse engineering of > ANDA reproduction of API & drug product > Laboratory testing API Services & Chemical Development purification & yield drug products > Laboratory testing of API & drug product > EPO hearing > Batch to batch variation > Scale up problems > Strategy development Inhalation Services > Expert report Drug Product Issues > Particle engineering > Expert witnessing > Dissolution > Cocrystals > Stability > Micronisation > Amorphous content & control Crystal Engineering > Moisture content & > Crystal modification hygroscopicity Crystallisation Development > Process development, scale-up Biomarker Discovery & Development
  • 3. www.almacgroup.com Commercial Services Preformulation Services Design and development capability for small molecules and biologics Clinical Technologies Our preformulation studies are designed to identify and select the optimal physical form of your API. We know that by possessing a thorough understanding of the properties of your drug substance, we can reduce the number of problems in development, lower development costs and decrease development time. Clinical Trial Supply Determining & assessing the Peptide structural characterisation solid state properties > LC-MS > Crystallinity > Absorption & fluorescence > Hygroscopicity spectroscopy > Particle size, shape & > Circular dichroism spectroscopy surface area > NMR Analytical Services > Moisture/solvent content Peptide chemical stability Solid state stability > Solution state chemical stability to Solution state stability acid, base, oxidising media, light & Plasma stability elevated temperatures > Solid state chemical stability to Biopharmaceutical profiling light, humidity & temperature Pharmaceutical Development > pH-solubility profile & pKa determination Formulation development studies > Permeability & BCS classification > Effect of pH > Solubility in pharmaceutical > Buffer concentration & buffer type solvents > Surfactants > Solubility in physiological buffers > Complexing agents > Polymers & cosolvents Animal formulation development Compatibility & stability studies > pH modifications > In a range of containers & closures; API Services & Chemical Development > Cosolvents assessed for peptide adsorption, > Surfactants compatibility, glass leachates & > Cyclodextrin inclusion complexes particulate formation. > Lipid based formulations Other parameters assessed: Clinical formulation > Osmolarity > Micronised powders/suspensions > Viscosity > Solid/waxy dispersions > pH > Lipid based formulations > Appearance > Drug in capsule/bottle > Needle flowability > Identification of impurities during stress studies Biomarker Discovery & Development For European Enquiries: For American Enquiries: Almac Almac Group Incorporated Sciences 25 Fretz Road Almac House Souderton, PA 18964 20 Seagoe Industrial Estate, United States of America Craigavon, BT63 5QD, T +1 (215) 660 8500 United Kingdom. E: sciences@almacgroup.com T: +44 (0) 28 3833 2200 E: sciences@almacgroup.com www.almacgroup.com